ADMA Biologics - M&A Summary and Business Overview

Life ScienceCompany

ADMA Biologics M&A Summary

ADMA Biologics has acquired 1 company.

ADMA Biologics’ largest acquisition to date was in 2017, when it acquired Biotest Pharmaceuticals - US Therapy Business for $40M. ADMA Biologics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

ADMA Biologics Business Overview

Where is ADMA Biologics headquartered?

ADMA Biologics is headquartered in Ramsey, New Jersey.

What is ADMA Biologics’ revenue?

ADMA Biologics disclosed revenue of 258M USD for 2023 and 154M USD for 2022.

How many employees does ADMA Biologics have?

ADMA Biologics has 624 employees.

What sector is ADMA Biologics in?

ADMA Biologics is a life science company.

When was ADMA Biologics founded?

ADMA Biologics was founded in 2004.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1
  • M&A Advisors 3

ADMA Biologics

ADMA Biologics, Inc.

465 State Route 17,
Ramsey, New Jersey 07446
United States,
(201) 478-5552
www.admabiologics.com

ADMA Biologics is a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the proposed treatment of Immune Deficiencies and the prevention and treatment of certain infectious diseases. ADMA's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $40M $40M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Biotest Pharmaceuticals Corp. - US Therapy Business 2017-01-23 40M USD Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 40M (100%) - -
Total 1 $40M - -

By Geo

State/Country Buy Value Sell Value
United States 1 40M - -
Total 1 $40M - -

Top M&A Advisors

Financial Deals
PJT Partners, Inc.
1
Raymond James - Investment Banking
1
Legal Deals
Paul, Weiss, Rifkind, Wharton & Garrison
1

Deal Values

buy # Total
< $100M 1 $40M
TOTAL $40M
Largest Biotest Pharmaceuticals Corp. - US Therapy Business
$40M (2017-01-23)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.